View in EDS

Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.

Saved in:
Bibliographic Details
Title: Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study.
Authors: Burnham, Samantha C1 (AUTHOR), Raghavan, Nandini2 (AUTHOR), Wilson, William3 (AUTHOR), Baker, David4 (AUTHOR), Ropacki, Michael T5 (AUTHOR), Novak, Gerald2 (AUTHOR), Ames, David6,7 (AUTHOR), Ellis, Kathryn6 (AUTHOR), Martins, Ralph N8,9 (AUTHOR), Maruff, Paul10 (AUTHOR), Masters, Colin L11 (AUTHOR), Romano, Gary2 (AUTHOR), Rowe, Christopher C12,13 (AUTHOR), Savage, Greg14 (AUTHOR), Macaulay, S Lance15 (AUTHOR), Narayan, Vaibhav A2 (AUTHOR), Alzheimer’s Disease Neuroimaging Initiative (CORPORATE AUTHOR), AIBL Research Group (CORPORATE AUTHOR)
Source: Journal of Alzheimer's Disease. 2015, Vol. 46 Issue 4, p1079-1089. 11p.
Database: Academic Search Ultimate
Description
ISSN:13872877
DOI:10.3233/JAD-143015